Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
Brigham and Women's Hospital · Harvard University · +3 more institutions
Indexed incrossrefpubmed
Abstract
RAAS Inhibitors in Patients with Covid-19 The effects of renin–angiotensin–aldosterone system blockers on angiotensin-converting enzyme 2 levels and activity in humans are uncertain. The authors hy...
Citation impact
2,169
total citations
- FWCI
- 281.31
- Percentile
- 100%
- References
- 71
Citations per year
Authors
6- MVMuthiah VaduganathanCorresponding
Brigham and Women's Hospital, Harvard University, British Heart Foundation
- OVOrly Vardeny
University of Minnesota, British Heart Foundation, Minneapolis VA Health Care System
- TMThomas Michel
Brigham and Women's Hospital, Harvard University, British Heart Foundation
- JJJohn J.V. McMurray
British Heart Foundation
- MAMarc A. Pfeffer
Brigham and Women's Hospital, Harvard University, British Heart Foundation
Topics & keywords
Topics
Keywords
- Renin–angiotensin system
- Aldosterone
- Coronavirus disease 2019 (COVID-19)
- Internal medicine
- Medicine
- Peptidyl-Dipeptidase A
- Angiotensin-converting enzyme 2
- Angiotensin-converting enzyme
No related works found for this paper.